Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
Clinical trial NCT05640791 · RECRUITING
Trial details
- NCT number
- NCT05640791
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2023-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.